Xcout IntelBIOPHARMA CREDIT PLC competitors & alternatives
The 12 closest competitors and alternatives to BIOPHARMA CREDIT PLC among asset management companies — ranked by similarity to what BIOPHARMA CREDIT PLC actually does, not by market-cap band.
Subscribe to see BIOPHARMA CREDIT PLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About BIOPHARMA CREDIT PLC
Operating as an investment trust since its founding in 2016 in Exeter, United Kingdom, BioPharma Credit PLC concentrates its investments on interest-bearing debt assets. These assets are financially backed by royalties or other revenue derived from the sales of established life sciences products.
BIOPHARMA CREDIT PLC at a glance
BIOPHARMA CREDIT PLC is an asset management company headquartered in Riverton, United Kingdom, founded in 2016. Xcout tracks 2 named people at BIOPHARMA CREDIT PLC, including Robert E. Thrailkill (Chairman of the Board, Chief Executive Officer and President).
BIOPHARMA CREDIT PLC leadership
- Robert E. ThrailkillChairman of the Board, Chief Executive Officer and President
- Sherry L. MooreChief Financial Officer, Principal Accounting Officer, Secretary & Director
Top 12 BIOPHARMA CREDIT PLC competitors
Ranked by semantic similarity — how close each company is to BIOPHARMA CREDIT PLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar asset management company
CT Healthcare Trust Plc is a real estate investment trust, which engages in the provision of shareholders with capital growth and income over the long term. The company was founded on October 7, 2016 and is headquartered in London, the United Kingdom.
Similar asset management company
The Biotech Growth Trust PLC, a closed-ended equity investment vehicle, was originally established by Frostrow Capital LLP and is jointly managed by OrbiMed Capital LLC. Formed on May 20, 1997, and legally based in the United Kingdom, this trust allocates its capital to global public equity markets. Its primary objective is to invest in shares of companies operating within the biotechnology sector, spanning the full range of market capitalizations. The construction of its investment portfolio relies on rigorous fundamental analysis, and its performance is benchmarked against the NASDAQ Biotechnology Index. It was previously identified as Finsbury Emerging Biotechnology Trust PLC.
Similar asset management company
VPC Specialty Lending Investments Plc operates as an investment vehicle, focusing its capital on opportunities within the specialized finance sector, primarily identifying and pursuing these ventures through digital lending platforms.
Similar asset management company
Merchants Trust PLC operates as an independent investment fund based in the United Kingdom. Its primary aim is to generate a superior level of income and consistent income growth, alongside sustained capital appreciation, for its investors. To achieve this, the Trust predominantly allocates capital to high-dividend-paying companies listed on the UK FTSE 100 index. The portfolio is broadly diversified across numerous industries, encompassing energy (such as oil, gas, electricity, mining, and multi-utilities), financial services (including banks, life insurance, and real estate investment trusts), healthcare (pharmaceuticals and biotechnology), various consumer sectors (like tobacco, beverages, general retail, and media), infrastructure (construction and materials), telecommunications, and other specialized areas such as travel and leisure, support services, and aerospace and defense.
Similar asset management company
Schroder British Opportunities Trust PLC operates as a UK-domiciled investment vehicle. Its core strategy involves deploying capital into a blend of both publicly traded and privately held equity stakes, with a strong emphasis on companies based within the United Kingdom.
Similar asset management company
Established in 2019, Riverstone Credit Opportunities Income Plc maintains its primary corporate office in the United Kingdom.
Similar asset management company
RM Secured Direct Lending plc operates as a publicly traded investment management firm. Its investment activities span international markets, with a core focus on alternative investments designed to generate consistent income. The firm cultivates a diversified portfolio primarily comprising loans extended to UK-based small and medium-sized enterprises (SMEs), mid-market corporations, and private individuals. These financial instruments encompass various debt structures, such as senior, subordinated, unitranche, and mezzanine debt, which can be documented as traditional loans, promissory notes, leases, bonds, or convertible bonds. Typically, these loans feature maturities ranging from two to ten years. Established in 2010, RM Secured Direct Lending plc is headquartered in Edinburgh, United Kingdom, with a supplementary office located in London.
Similar asset management company
Oxford Technology 2 VCT Plc functions as a venture capital trust, primarily channeling investments into nascent technology companies. These enterprises are specifically targeted within a 60-mile radius of Oxford. Additionally, the fund allocates capital to privately held, UK-based firms across the science, technology, and engineering sectors.
Similar asset management company
The Brunner Investment Trust PLC is an investment company that builds a diversified portfolio aimed at long-term wealth creation, growth, and income. It provides investment products and services targeted at individuals residing in the United Kingdom.
Similar asset management company
British Smaller Companies VCT 2 plc operates as a venture capital trust, concentrating its investments on businesses seeking capital for emerging growth, expansion, acquisitions, and development projects. This evergreen investment vehicle diversifies its portfolio across various securities, including common and preference shares, as well as fixed income instruments like corporate bonds and government gilts, encompassing both VCT-qualifying and non-qualifying assets. The trust actively seeks out firms in sectors such as proprietary technologies, business and industrial services, manufacturing, healthcare, software, information technology, telecommunications, retail, and consumer brands. Its primary geographic focus is the United Kingdom. Individual investments range from £1 million to £10 million, targeting companies with annual revenues between £5 million and £25 million. The VCT generally aims to secure a majority ownership stake, with investments typically held for an average duration of seven years.
Similar asset management company
Triple Point Venture VCT Plc functions as a dedicated venture capital trust, actively seeking out investment prospects across the United Kingdom. This fund primarily targets companies operating within the technology, renewable energy, and asset finance industries. It provides essential capital for businesses in their early developmental stages and those requiring funding for growth and expansion. The trust's investment strategy is diverse, extending across real estate, debt instruments, infrastructure projects, venture capital, and both public and private equity holdings, with a minimum investment threshold set at £30,000.
Similar asset management company
British & American Investment Trust Plc operates as a closed-end investment trust. It invests predominantly in investment trusts and in other UK and U.S. quoted companies to maintain a balance of income and growth. The company was founded on June 4, 1947 and is headquartered in London, the United Kingdom.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of BIOPHARMA CREDIT PLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for BIOPHARMA CREDIT PLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →